Literature DB >> 30504677

Multiple Combination of Angelica gigas Extract and Mesenchymal Stem Cells Enhances Therapeutic Effect.

Ran Kim1, Pilseog Kim1, Chang Youn Lee2, Seokyeon Lee1, Hwayoung Yun3, Min Young Lee4, Jongmin Kim5, Kyungmin Baek6, Woochul Chang1.   

Abstract

Alternative medicines attract attention because stroke is rarely expected to make a full recovery with the most advanced medical technology. Angelica gigas (AG) is a well-known herbal medicine as a neuroprotective agent. The present study introduced mesenchymal stem cells (MSCs) to identify for the advanced treatment of the cerebrovascular disease. The objective of this research is validation of the enhanced effects of multiple combined treatment of AG extract with MSCs on stroke through angiogenesis. Our results confirmed that AG extract with MSCs improved the neovascularization increasing expression of angiogenesis-regulated molecules. The changes of brain and the behavioral ability showed the increased effects of AG extract with MSCs. As a result, AG extract and MSCs may synergistically increase the therapeutic potential by enhancing neovascularization. This mixed approach provides a new experimental protocol of herbal medicine therapy for the treatment of a variety of diseases including stroke, trauma, and spinal cord injury.

Entities:  

Keywords:  Angelica gigas extract; brain ischemic stroke; mesenchymal stem cell; multiple combined treatment

Mesh:

Substances:

Year:  2018        PMID: 30504677     DOI: 10.1248/bpb.b18-00193

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke.

Authors:  Yong-Hua Zhao
Journal:  Chin J Integr Med       Date:  2019-11-28       Impact factor: 1.978

Review 2.  Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke.

Authors:  Yinghan Guo; Yucong Peng; Hanhai Zeng; Gao Chen
Journal:  Stem Cells Int       Date:  2021-06-15       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.